Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug ...
Rockville, Maryland Friday, January 9, 2026, 10:00 Hrs [IST] ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug (IND) clearance from the U.S. FDA, marking another major expansion to the co ...
PKM2 acts like a switch for cellular energy, directly determining whether cancer cells can rapidly generate energy and biosynthetic precursors to support their continued growth. Using a driving ...
A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...
News-Medical.Net on MSN
Neural pain pathways found to play crucial role in bone fracture healing
When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the ...
The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...
Roche expects filing for up to three new molecular entities in 2026, and accelerating its pipeline through partnerships and ...
Company to host conference call and webcast at 8:30 a.m. ET on Thursday, January 8, 2026WATERTOWN, Mass., Jan. 06, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback